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Abstract
Background: Dynamic cerebral autoregulation after intracerebral hemorrhage (ICH) remains poorly understood. We
performed a case-control study to compare dynamic autoregulation between ICH patients and healthy controls.
Methods: Twenty-one patients (66 ± 15 years) with early (< 72 hours) lobar or basal ganglia ICH were
prospectively studied and compared to twenty-three age-matched controls (65 ± 9 years). Continuous measures of
mean flow velocity (MFV) in the middle cerebral artery and mean arterial blood pressure (MAP) were obtained over
5 min. Cerebrovascular resistance index (CVRi) was calculated as the ratio of MAP to MFV. Dynamic cerebral
autoregulation was assessed using transfer function analysis of spontaneous MAP and MFV oscillations in the low
(0.03-0.15 Hz) and high (0.15-0.5 Hz) frequency ranges.
Results: The ICH group demonstrated higher CVRi compared to controls (ipsilateral: 1.91 ± 1.01 mmHg·s·cm
-1, p =
0.04; contralateral: 2.01 ± 1.24 mmHg·s·cm
-1, p = 0.04; vs. control: 1.42 ± 0.45 mmHg·s·cm
-1). The ICH group had
higher gains than controls in the low (ipsilateral: 1.33 ± 0.58%/mmHg, p = 0.0005; contralateral: 1.47 ± 0.98%/
mmHg, p = 0.004; vs. control: 0.82 ± 0.30%/mmHg) and high (ipsilateral: 2.11 ± 1.31%/mmHg, p < 0.0001;
contralateral: 2.14 ± 1.49%/mmHg, p < 0.0001; vs. control: 0.66 ± 0.26%/mmHg) frequency ranges. The ICH group
also had higher coherence in the contralateral hemisphere than the control (ICH contralateral: 0.53 ± 0.38, p = 0.02;
vs. control: 0.38 ± 0.15) in the high frequency range.
Conclusions: Patients with ICH had higher gains in a wide range of frequency ranges compared to controls. These
findings suggest that dynamic cerebral autoregulation may be less effective in the early days after ICH. Further
study is needed to determine the relationship between hematoma size and severity of autoregulation impairment.
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Background
Cerebral autoregulation serves as a protective feedback
mechanism to maintain relatively constant blood flow to
the brain in response to changes in cerebral perfusion
pressure (CPP) [1]. However, cerebrovascular injuries
can impair cerebral autoregulation [2-4] and may result
in undesirable ischemia or hyperemia with changes in
CPP. Recent studies have demonstrated the importance
of impaired cerebral autoregulation as a potential contri-
butor to secondary neuronal damage after traumatic
brain injury (TBI) [5], subarachnoid hemorrhage (SAH)
[6], ischemic stroke [7] and intracerebral hemorrhage
(ICH) [8]. With increasing emphasis on assessing
cerebral autoregulation as an important physiologic vari-
able, an emerging concept called “autoregulation-
oriented therapy” is beginning to focus on individually
adjusting the CPP to compensate for the cerebral auto-
regulatory status for each patient [9].
The understanding of cerebral autoregulation is espe-
cially important in ICH since blood pressure manage-
ment is the mainstay of current treatment options [10].
With impaired cerebral autoregulation, aggressive lower-
ing of blood pressure may lead to undesirable cerebral
ischemia; but maintaining high blood pressure may the-
oretically lead to hyperemia and hematoma expansion.
Hence, adjusting blood pressure with the understanding
of cerebral autoregulation status may be more effective
in maintaining optimal cerebral blood flow, which could
potentially lead to better outcomes. Although studies
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tic” cerebral autoregulation in the peri-hematoma region
is likely preserved after ICH [11-13], there are limited
data on “dynamic” cerebral autoregulation after ICH
[14]. Thus, we conducted a case-control study to com-
pare dynamic cerebral autoregulation capacity between
patients with acute ICH and community-dwelling
healthy subjects.
Static vs. Dynamic Cerebral Autoregulation
Most of the early studies of cerebral autoregulation were
assessed by gradually raising or lowering blood pressure
and measuring the cerebral blood flow (CBF) responses
to determine if steady-state CBF values have changed
[1,15]. This method reflects static cerebral autoregula-
tion and captures the steady-state relationship between
gradual changes in pressure and flow [16]. Most of the
neuroimaging studies assessing the changes in CBF or
oxygen extraction fraction (OEF) with changes in blood
pressure reflect the “static” component of cerebral auto-
regulation. In contrast, dynamic cerebral autoregulation
measurements assess the “robustness” of dynamic cere-
bral vessel caliber changes in response to sudden
changes in blood pressure, which cannot be assessed
with most static imaging techniques.
Methods
TCD Ultrasound and Dynamic Cerebral Autoregulation
TCD ultrasound is a noninvasive and readily available
diagnostic tool that can be used to assess dynamic cere-
bral autoregulation. Recent developments in Doppler
technology have enabled researchers to measure sponta-
neous beat-to-beat changes in mean blood flow velocity
(MFV) of the major cerebral arteries in response to spon-
taneous mean arterial pressure (MAP) oscillations, allow-
ing investigators to quantify the dynamic relationship
between MFV and MAP without the substantial risk of
manipulating blood pressure [17]. This allows assessment
of “dynamic” cerebral autoregulation by analyzing the
beat-to-beat spontaneous oscillations of MFV and MAP
[18]. Dynamic cerebral autoregulation can be determined
by the transfer function gains and phase shift angles of
the two oscillating signals. In the cerebral circulation, the
gain of the blood pressure-flow transfer function quanti-
fies the damping effect of cerebral autoregulation on the
magnitude of blood pressure oscillations. A low gain
value indicates intact dynamic cerebral autoregulation,
whereas a high gain value can be interpreted as impaired
dynamic cerebral autoregulation [18,19]. The phase shift
represents the temporal difference between blood flow
oscillations with respect to blood pressure oscillations
and is considered a surrogate measures for the time delay
of the autoregulatory response. If oscillations of cerebral
blood flow and blood pressure are synchronous (i.e.,
phase shift = 0 degrees), then they are in phase and indi-
cate impaired dynamic cerebral autoregulation, whereas
phase shifts approaching 90 degrees indicate more effi-
cient dynamic cerebral autoregulation [18,20]. Because
dynamic cerebral autoregulation is a relatively slow pro-
cess and can take 2-10 seconds to engage [17], fre-
quency-domain analysis of dynamic autoregulation is
typically studied at frequency ranges < 0.15 Hz [21].
Subjects
The study received approval from the Brigham and
Women’s Hospital institutional ethical standards com-
mittee on human experimentation for any experiments
using human subjects. A written consent was obtained
from the subjects or their healthcare proxies.
ICH Patients
From August 2007 to June 2009, we prospectively
screened 37 patients admitted to the neurointensive care
unit at Brigham and Women’s Hospital with diagnosis
of spontaneous ICH. Inclusion criteria were age greater
than 18, evidence of acute ICH on admission by com-
puted tomography (CT), symptom onset within 72
hours from the study and hemodynamic stability. Exclu-
sion criteria included traumatic hemorrhage, history of
chronic obstructive lung disease, unstable blood pres-
sure requiring vasopressor agents, other central neurolo-
gical co-morbidities (e.g. central nervous system
vasculitis, multiple sclerosis, sickle cell disease, or
tumor) and inadequate TCD windows. All head CT
scans were reviewed independently by one of the study
investigators (K.N.) using a standardized protocol,
blinded to cerebral hemodynamic data, and hematoma
volume was calculated from the most recent brain CT
prior to the TCD study by using the “ABC/2” volume
method [22]. The location and etiology of ICH were
determined by one of the investigators (K.N.) based on
clinical history and CT findings. Because our TCD
method was intended to assess cerebral autoregulation
capacity primarily in the middle cerebral artery (MCA)
distribution, we excluded patients with thalamic (4
patients), pontine (2 patients) and primary intraventricu-
lar hemorrhage (1 patient) in the final analysis. We also
excluded 1 patient with hemorrhage related to arteriove-
nous malformation (AVM) because AVM’su n i q u ef l o w
dynamic may affect cerebral autoregulation. Three
patients were excluded because time-to-study exceeded
72 hours from the symptom onset. A total of 21 patients
with lobar or basal ganglia ICH with adequate TCD
window for MCA insonation were included in the study.
Control Group
Twenty-three age-matched healthy subjects (65 ± 9
years) with no history of stroke or major vascular risk
Nakagawa et al. BMC Neurology 2011, 11:108
http://www.biomedcentral.com/1471-2377/11/108
Page 2 of 8factors were drawn from a group of control subjects
involved in another study [23]. In the control group,
only the right MCA MFV was measured and used for
comparative analysis.
Study Procedures
Upon arrival to the emergency department, each patient
underwent baseline brain CT and evaluation by a neu-
rologist. The subjects were placed in a 30-degree recum-
bent position on a standard hospital bed. They were
instrumented for measurement of heart rate and non-
invasive beat-to-beat arterial blood pressure monitoring
(Finapres, Ohmeda Monitoring Systems, Englewood,
CO) as previously described [24]. TCD ultrasonography
(Multi Dop X4, DWL-Transcranial Doppler Systems
Inc., Sterling, VA) was used to measure changes in
MCA MFV. The MCA signals were identified on ipsilat-
eral and contralateral sides (hemorrhagic and nonhe-
morrhagic hemispheres) according to the criteria of
Aaslid et al. [25] and recorded simultaneously for 5
minutes. A Spencer probe fixation device was used to
stabilize the Doppler probes for the duration of the
study. The envelope of the velocity waveform, derived
from a fast Fourier analysis of the Doppler frequency
signal, was digitized at 500 Hz, displayed simultaneously
with the blood pressure waveform and stored for later
off-line analysis. In the control group, MCA MFV and
blood pressure were recorded in the supine position
using a similar technique.
Data Analysis
All data were displayed and digitized in real time at 500
Hz with commercially available data acquisition software
(Windaq, Dataq Instruments). The beat-to-beat cycles
were determined by detecting the peak of each arterial
pressure waveform and flow velocity waveform. The
MAP and MFV values were determined from the inte-
grals of each waveform using a custom Matlab program
to calculate the systolic and diastolic blood flow velocity
from peak and minimum TCD values within each beat
cycle. Cerebrovascular resistance index (CVRi)w a sc a l -
culated as the ratio of MAP to MFV. Heart rate was
determined from peak to peak times. All data segments
for MAP and MFV were visually inspected and edited
for artifact and ectopy, and only steady-state data were
used for analysis.
A power spectrum analysis technique based on the
Welch algorithm of averaging periodograms was used.
T h e5 - m i n u t et i m es e r i e sw e r ei n t e r p o l a t e da t1 0 0H z
to obtain equidistant time intervals. For fast Fourier
analysis a Hanning window of 30 seconds was used with
two-third overlap and transformed to its frequency
representation squared. The periodograms were aver-
aged to produce the spectrum estimate. Coherence
between MAP and MFV were calculated from the cross-
spectra and autospectra of steady-state data segments as
follows: (cross-spectra)
2/(input signal autospectrum) ×
(output signal autospectrum). Transfer functions were
determined by dividing the cross-spectrum by the input
autospectrum for each vessel insonated [19]. With a
custom MATLAB program, transfer gains and phases
were calculated for each subject using the MAP and
normalized MFV signal autospectra (in percentage
change in cm/s/mm Hg) over the two specified fre-
quency ranges: low (0.03-0.15 Hz) and high (0.15-0.5
Hz). The MCA MFV was normalized to account for
inter-subject variability [4].
Statistical Analysis
Data were analyzed using commercially available statisti-
cal software (SPSS 18.0, Chicago, IL). Descriptive statis-
tics were used to describe patient characteristics, clinical
data and hematoma sizes. Inter-group differences were
tested using c
2 test for categorical data and t-test for
normally distributed continuous variables. Within the
ICH group, intra-individual differences in MFV, transfer
function coherence, gains, and phases between the ipsi-
lateral and contralateral sides were tested using a
repeated measures two-way ANOVA using hematoma
size as a covariate. Relationships between hematoma
size and coherence, gains and phases were tested using
Pearson correlation analysis. Data are presented as mean
± SD, and levels of p < 0.05 are considered statistically
significant.
Results
Clinical and hemodynamic characteristics are shown
(Table 1). Mean time from symptom onset to the TCD
measurement in the ICH group was 34 ± 14 hours.
Eight patients (38%) had hypertensive hemorrhage, 4
patients (19%) had warfarin-related hemorrhage, 2
patients (10%) had hemorrhage due to probable cerebral
amyloid angiopathy (CAA), 1 patient (5%) had hemor-
rhage related to venous sinus thrombosis, and 4 patients
(19%) had hemorrhage of undetermined etiology. The
mean hematoma volume was 36 ± 27 cm
3.N o n eo ft h e
subjects required surgical evacuation of the space-occu-
pying hematoma. The ICH group demonstrated lower
MCA MFV on both sides and higher CVRi compared to
controls (Table 1).
Figure 1 presents the results of the cross-spectral
function analysis for the ICH group and the control.
Overall, the transfer function gains for the ICH group
were greater than that for the control for the majority
of harmonics in the frequency range 0.03-0.5 Hz. When
grouped into two frequency ranges: low (0.03-0.15 Hz)
and high (0.15-0.5 Hz), the ICH group showed higher
gains than the control in the low frequency range
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eral: 1.47 ± 0.98%/mmHg, p = 0.004; vs. control: 0.82 ±
0.30%/mmHg) and high frequency range (ipsilateral:
2.11 ± 1.31%/mmHg, p < 0.0001; contralateral: 2.14 ±
1.49%/mmHg, p < 0.0001; vs. control: 0.66 ± 0.26%/
mmHg) (Figure 2). Furthermore, the ICH group also
had higher coherence in the contralateral hemisphere
than the control (ICH contralateral: 0.53 ± 0.38 vs. con-
trol: 0.38 ± 0.15, p = 0.02;) in the high frequency range
(Figure 2).
Within the ICH group, comparison of MFV, CVRi,
coherence, gains, and phases between the ipsilateral and
contralateral sides showed no significant differences.
Pearson correlation analyses showed significant correla-
tion between hematoma size and gains in the low and
high frequency ranges in both hemisphere (Figure 3).
Discussion
Our study shows that compared to healthy controls,
patients with lobar or basal ganglia ICH have higher MCA
transfer gains in both hemispheres involving a wide range
of frequencies. These findings suggest that dynamic cere-
bral autoregulation is less effective in ICH patients.
Dynamic cerebral autoregulation is a relatively slow-
responding process and thought to primarily operate in
the lower frequency ranges (i.e. < 0.15 Hz). The increased
gain seen in the low frequency range in our study supports
the concept that slow-responding dynamic cerebral auto-
regulation is less effective in the ICH patients.
Interestingly, gains in the high frequency range (0.15-
0.5 Hz), a frequency range that is considered a much
faster response (2-7 seconds) than what is generally con-
sidered for dynamic cerebral autoregulation, were also
greater in the ICH group. Panerai et al. have shown
similar results in a group of neonates where those with
normal cerebral autoregulation had lower transfer gain
Table 1 Clinical and Hemodynamic Characteristics
ICH Control P value
N 21 23
Age, yr 66 ± 15 65 ± 9 0.80
Gender (male:female) 8:13 8:15 0.82
ICH Size, cm
3 36 ± 27 NA
Diabetes mellitus, n (%) 4 (19) NA
Hypertension, n (%) 12 (57) NA
Secondary IVH, n (%) 7 (33) NA
Location of hematoma, n (%) NA
Lobar 13 (62)
Basal Ganglia 8 (38)
Time to TCD, hr 34 ± 14 NA
SBP, mmHg 130 ± 26 134 ± 26 0.59
DBP, mmHg 53 ± 13 65 ± 19 0.02
MAP, mmHg 77 ± 15 89 ± 21 0.04
Heart rate, beat/min 74 ± 11 63 ± 14 0.005
MCA MFV, cm/s
Ipsilateral 49.8 ± 22.5 66.6 ± 18.9 0.01
Contralateral 50.6 ± 24.2 0.02
MCA CVRi, mmHg·s·cm
-1
Ipsilateral 1.91 ± 1.01 1.42 ± 0.45 0.04
Contralateral 2.01 ± 1.24 0.04
Figure 1 Cross-spectral function analysis for the ICH group and
the control. Cross-spectral function analyses of the beat-to-beat
mean arterial pressure and middle cerebral artery mean flow
velocity in the 0.03-0.5 Hz ranges were used to determine the gain,
coherence and phase values for the ICH group (ipsilateral and
contralateral sides) and the control group.
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to those with impaired cerebral autoregulation [26].
Although it is possible that the differences in gain seen
in this high frequency may reflect systemic hemody-
namic factors seen in neurocritical care patients com-
pared to the controls, we speculate that it may also
reflect the faster myogenic response of the small vessels.
The high frequency gain has been correlated with CO2
reactivity and also inversely correlated with the degree
of proximal artery stenosis, [27] and thus may reflect a
fast vasomotor response. However, the clinical impor-
t a n c eo ft r a n s f e rg a i nv a l u e si nt h i sh i g hf r e q u e n c y
range is uncertain, and its relationship to the mechan-
ism of dynamic cerebral autoregulation needs to be
further investigated.
Our findings are also consistent with the study by
Schramm et al. [14] which showed that dynamic cere-
bral autoregulation of both hemispheres were impaired
after acute brain injury from day 1 to 4 with a nadir on
day 4. Compared to their study, which was limited by
the small sample size and mixed cases (4 ICH and 12
TBI patients), we were able to show similar findings
with the non-traumatic ICH patients with a greater
number of patients. Furthermore, the significant correla-
tion between hematoma size and gains on both
Figure 2 Transfer function analysis for the ICH group and
controls. Comparison of transfer function gain, coherence, and
phase in the low (0.03-0.15 Hz) and high (0.15-0.5 Hz) frequency
ranges between the ICH group (n = 21) and controls (n = 23).
Values are expressed as mean (bar) ± SD (error bar). Ipsilateral and
contralateral sides of the ICH group were compared to controls.
Significant differences between the two groups are shown. *p <
0.01, **p < 0.001, ***p < 0.0001.
Figure 3 Relationship between hematoma size and transfer
function gain in the ICH group. Within the ICH group (n = 21),
correlation between hematoma size and transfer function gain at
0.03-0.15 Hz and 0.15-0.5 Hz frequency ranges are shown. Lines
represent linear regression for ipsilateral (dashed lines) and
contralateral (solid lines) hemisphere.
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presence of hematoma may have more direct impact on
dynamic autoregulation. Interestingly, these correlations
between hematoma size and gains were more prominent
in the high frequency. We speculate that large hemato-
mas are associated with higher intracranial pressure and
lower intracranial compliance compared to smaller
hematomas. With lower compliance, the affected area of
the brain would be “stiffer” and may impair the fast-
responding myogenic response. Another possible expla-
nation is that with higher intracranial pressure, the cere-
bral perfusion pressure would likely be reduced, which
may also impair cerebral autoregulation. These explana-
tions would be consistent with the findings of Panerai et
al. [28] who showed that in severe head injury patients,
the high ICP group had greater deterioration of dynamic
cerebral autoregulation than the low ICP group. Unfor-
tunately, we did not have ICP measurements on our
patients so we could not examine the relationship
between ICP and blood flow in these patients.
Since our measurements were made post ictus and we
do not have any pre ICH measures, we can not rule out
the possibility that dynamic cerebral autoregulation was
already impaired in the ICH group prior to hemorrhage
due to underlying vascular risk factors such as hyperten-
s i o n .I nf a c t ,t h estatic cerebral autoregulation curve is
thought to be shifted to the right in people with
untreated hypertension [29]. However, the dynamic cer-
ebral autoregulation has been shown to be preserved
with those with controlled or uncontrolled hypertension
[19]. Therefore, it is unlikely that our findings of bilat-
eral impairment of dynamic cerebral autoregulation in
ICH patients are explained by their long-standing his-
tory of hypertension.
Critical for the interpretation of our data is to under-
stand the extent to which the differences in MFV and
CVRi between the two groups may have contributed to
our observed differences in transfer gains. We speculate
that antihypertensive and sedative medications adminis-
tered to the ICH group as part of standard protocol [10]
likely resulted in the lower blood pressure and lower
MCA MFV seen in our ICH patients. Although it is
possible that these medications may have altered
dynamic cerebral autoregulation, we believe that these
effects were minimal because most of the patients
received intravenous labetalol for acute antihypertensive
treatment and intravenous propofol for sedation, neither
of which has been shown to impair cerebral autoregula-
tion [30,31]. The ICH group had lower MFV and higher
CVRi compared to controls, suggesting that the small
arteries and arterioles were likely more vasoconstricted
i nt h eI C Hg r o u p .S i n c em a n ys t u d i e ss u g g e s tm o r e
effective cerebral autoregulation with vasoconstriction
[19,32,33]; this could not explain why our ICH patients
with higher CVRi (more vasoconstriction) had higher
transfer gains than controls. This further supports the
hypothesis that compared to healthy controls, dynamic
cerebral autoregulation of the ICH patients is intrinsi-
cally more impaired, independent of the effect of vessel
caliber.
Another important factor to note is the potential
effect of blood pressure variability on transfer gain. The-
oretically, if patients have significantly higher blood
pressure variability, it may be more difficult for even
intact autoregulation to compensate for this variability.
However, our ICH patients had lower blood pressure
variability than the control group, and thus the higher
gain seen in the ICH patients suggests that even with
reduced blood pressure changes, autoregulation was still
unable to compensate effectively.
To date, there is no intervention that significantly
improves clinical outcome after spontaneous ICH. Sev-
eral clinical trials are currently ongoing to test whether
aggressive blood pressure lowering prevents hematoma
expansion and improves clinical outcome [34-36]. How-
ever, none of the studies are addressing cerebral autore-
gulation as a potential contributing factor for hematoma
expansion and clinical outcome. Recent studies suggest
that cerebral autoregulation status is associated with
clinical outcome after spontaneous ICH [8,37]. Specifi-
cally, a study by Reinhard et al. has shown that ICH
patients who had cerebral autoregulation deterioration
between day 3 and 5 were associated with poor 3-
month functional outcome [37]. Although it is uncertain
whether subacute deterioration in autoregulation merely
reflects the severity of the disease or whether it contri-
butes to secondary neuronal injury and poor outcome,
these studies support the idea that frequent monitoring
of cerebral autoregulation status may be needed in
selected ICH patients.
Study Limitations
This was an exploratory case-control study to assess the
differences in dynamic cerebral autoregulation between
patients with acute spontaneous ICH and healthy con-
trols. The lack of a separate control group with similar
vascular risk factors is the major limitation of the study
s i n c ew ew e r eu n a b l et od i r e c t l ya d d r e s sw h e t h e ro u r
observation was due to their underlying chronic vasculo-
pathy or due to acute deterioration as a result of acute
ICH. Furthermore, since the patients treated in the
intensive care unit may have other unaccounted factors
not present in the control group that could affect the
results of transfer function analysis, our results should
be interpreted with caution. Although we excluded sub-
jects with chronic obstructive lung disease, and none of
the patients had oxygenation or ventilation problems
during the study, alterations in PaCO2 or end-tidal CO2
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tivity and cerebral blood flow between patients. Our
study was conducted over a range of 72 hours from the
ictus, which may have combined the hyperacute and
early subacute stages of ICH, which may have differed.
Given the dynamic nature of neurocritical care patients
who may have fluctuating hemodynamic and autoregula-
tory status, one cerebral autoregulation measurement
from a 5 minute recording may not be sufficient to cap-
ture their overall cerebral autoregulatory status.
Conclusions
In conclusion, our study indicates that dynamic cerebral
autoregulation may be less effective in patients with
spontaneous lobar or basal ganglia ICH compared to
healthy controls. Our findings also suggest that dynamic
cerebral autoregulation may be further impaired in
patients with larger hematomas; however, a larger pro-
spective study is needed to confirm this observation.
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